SMTL ID : 7mf0.1

Co-crystal structure of PERK with inhibitor (R)-2-amino-N-cyclopropyl-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)nicotinamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.81 Å

Oligo State

monomer

Ligands

1 x Z6P: 2-amino-N-cyclopropyl-5-(4-{[(2R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino}-2-methylphenyl)pyridine-3-carboxamide(Non-covalent)

Z6P.1: 19 residues within 4Å: Chain A: L.27, V.35, A.48, K.50, L.71, L.74, I.79, V.80, Y.82, I.109, M.111, Q.112, L.113, C.114, R.115, F.167, G.177, D.178, F.179 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.35, A:A.48, A:K.50, A:L.71, A:L.71, A:V.80, A:V.80, A:Y.82, A:F.167 Hydrogen bonds: A:C.114, A:C.114, A:D.178, A:D.178, A:F.179

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Calvo, V. et al., Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors. Bioorg.Med.Chem.Lett. (2021)

Release Date

2021-05-19

Peptides

Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3

Related Entries With Identical Sequence